 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
Preclinical, Journal: Human amniotic epithelial stem cell-derived dopaminergic neuron-like cells ameliorate motor dysfunction in a rat model of Parkinson's disease. (Pubmed Central) - Jul 1, 2024
Our study has demonstrated evident therapeutic effects of hAESCs-DNLCs, and provides a safe and promising solution for PD.
- || human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
Trial completion: Stereotactic Transplantation of hAESCs for Parkinson's Disease (clinicaltrials.gov) - Apr 12, 2023
P1, N=3, Completed, Sponsor: Shanghai East Hospital
Our study has demonstrated evident therapeutic effects of hAESCs-DNLCs, and provides a safe and promising solution for PD. Active, not recruiting --> Completed
- || human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
Enrollment open: Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease (clinicaltrials.gov) - Feb 17, 2023
P1, N=18, Recruiting, Sponsor: Shanghai East Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- || human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
New P1 trial: Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease (clinicaltrials.gov) - Jan 19, 2023
P1, N=18, Not yet recruiting, Sponsor: Shanghai East Hospital
- || human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
Trial initiation date: Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease. (clinicaltrials.gov) - Oct 28, 2022
P1, N=12, Not yet recruiting, Sponsor: Shanghai East Hospital
Not yet recruiting --> Recruiting Initiation date: Jul 2022 --> Dec 2022
- || human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
New P1 trial: Precise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease. (clinicaltrials.gov) - Jun 27, 2022
P1, N=12, Not yet recruiting, Sponsor: Shanghai East Hospital
- | human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology
Enrollment closed, Trial completion date, Trial primary completion date: Stereotactic Transplantation of hAESCs for Parkinson's Disease (clinicaltrials.gov) - Jun 27, 2022
P1, N=3, Active, not recruiting, Sponsor: Shanghai East Hospital
Initiation date: Jul 2022 --> Dec 2022 Not yet recruiting --> Active, not recruiting | Trial completion date: Dec 2023 --> Feb 2023 | Trial primary completion date: Nov 2021 --> Feb 2023